Trial intelligence / Profile preview

Intravenous hydrocortisone to prevent postoperative sore throat

IRCT201104094005N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Jul 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in pharyngitis comparing Intravenous hydrocortisone with Placebo/control (2 arms). Primary endpoint: Incidence of postoperative sore throat. Started Jul 2009; status: completed.

02

Drugs

hydrocortisone
03

Conditions

pharyngitis

Beyond the preview

Go deeper on IRCT201104094005N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201104094005N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call